Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial.

William E KrausThomas YatesJaakko TuomilehtoJie-Lena SunLaine ThomasJohn J V McMurrayM Angelyn BethelRury R Holman

Published in: BMJ open diabetes research & care (2018)

Physical activity should be measured objectively in pharmacologic trials as it is a significant but underappreciated contributor to diabetes outcomes. It should be a regular part of clinical practice as well.

Keyphrases

physical activity
type diabetes
glycemic control
clinical practice
cardiovascular disease
body mass index
clinical trial
study protocol
phase iii
phase ii
peripheral blood
randomized controlled trial
weight loss